Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertoni

Showing results (11-20 of 325) with videos related to

Pageof 33
Sort By:
Trends in Cancer|January 1, 2022
An epigenetic signature in CD19-CAR T cells predicts clinical outcomeFederico Simonetta, Francesco Bertoni
British Journal of Haematology|August 2, 2022
United we stand: Double targeting of CD79B and CD20 in diffuse large B-cell lymphomaChiara Tarantelli, Francesco Bertoni
Current Opinion in Hematology|May 23, 2019
Bromodomain and Extra-Terminal domain inhibitors for lymphoid malignanciesFrancesco Bertoni, Anastasios Stathis
Cancer Discovery|December 22, 2017
BET Proteins as Targets for Anticancer TreatmentAnastasios Stathis, Francesco Bertoni
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
State-of-the-art therapeutics: marginal-zone lymphomaFrancesco Bertoni, Emanuele Zucca
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2005
Another Piece of the MALT Lymphomas JigsawEmanuele Zucca, Francesco Bertoni
Blood|December 31, 2016
Staining the target: CD37 expression in lymphomasFrancesco Bertoni, Anastasios Stathis
Best Practice & Research. Clinical Haematology|March 15, 2017
Methylation patterns in marginal zone lymphomaAlberto J Arribas, Francesco Bertoni
Haematologica|August 26, 2003
Pathogenesis and treatment of extranodal lymphomas: the fascinating model of mucosa-associated lymphoid tissue lymphomaEmanuele Zucca, Francesco Bertoni, Franco Cavalli
Oncology (Williston Park, N.Y.)|April 2, 2014
The management of nongastric MALT lymphomasEmanuele Zucca, Anastasios Stathis, Francesco Bertoni
Pageof 33

Showing results (11-20 of 325) with videos related to

Sort By:
Pageof 33
Trends in Cancer|January 1, 2022
An epigenetic signature in CD19-CAR T cells predicts clinical outcomeFederico Simonetta, Francesco Bertoni
British Journal of Haematology|August 2, 2022
United we stand: Double targeting of CD79B and CD20 in diffuse large B-cell lymphomaChiara Tarantelli, Francesco Bertoni
Current Opinion in Hematology|May 23, 2019
Bromodomain and Extra-Terminal domain inhibitors for lymphoid malignanciesFrancesco Bertoni, Anastasios Stathis
Cancer Discovery|December 22, 2017
BET Proteins as Targets for Anticancer TreatmentAnastasios Stathis, Francesco Bertoni
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
State-of-the-art therapeutics: marginal-zone lymphomaFrancesco Bertoni, Emanuele Zucca
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2005
Another Piece of the MALT Lymphomas JigsawEmanuele Zucca, Francesco Bertoni
Blood|December 31, 2016
Staining the target: CD37 expression in lymphomasFrancesco Bertoni, Anastasios Stathis
Best Practice & Research. Clinical Haematology|March 15, 2017
Methylation patterns in marginal zone lymphomaAlberto J Arribas, Francesco Bertoni
Haematologica|August 26, 2003
Pathogenesis and treatment of extranodal lymphomas: the fascinating model of mucosa-associated lymphoid tissue lymphomaEmanuele Zucca, Francesco Bertoni, Franco Cavalli
Oncology (Williston Park, N.Y.)|April 2, 2014
The management of nongastric MALT lymphomasEmanuele Zucca, Anastasios Stathis, Francesco Bertoni
Pageof 33